ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada · Delayed Price · Currency is CAD 0.4950
+0.0450 (10.00%)
At close: May 6, 2026
ZYUS Life Sciences Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.37 | 0.41 | 0.48 | 0.35 | 0.3 | 0.21 | |
Revenue Growth | -22.57% | -15.80% | 37.04% | 17.79% | 43.96% | - |
Cost of Revenue | 0.43 | 0.42 | 1.44 | 2.36 | 0.94 | 0.06 |
Gross Profit | -0.06 | -0.01 | -0.96 | -2.01 | -0.64 | 0.14 |
Selling, General & Admin | 6.92 | 7.92 | 8.92 | 12.33 | 9.34 | 12.48 |
Research & Development | 2.08 | 2.86 | 2.05 | 1.31 | 2.21 | 5.37 |
Other Operating Expenses | 0.09 | 0.28 | 0.49 | 0.35 | 0.37 | 0.66 |
Operating Expenses | 11.31 | 14.24 | 14.83 | 17.36 | 16.06 | 22.91 |
Operating Income | -11.37 | -14.25 | -15.79 | -19.37 | -16.7 | -22.77 |
Interest Expense | -2.97 | -2.41 | -0.76 | -3.27 | -5.24 | -1.46 |
Interest & Investment Income | 0.03 | 0.03 | 0.26 | 0.7 | 0.22 | - |
Currency Exchange Gain (Loss) | -0.02 | 0.03 | -0.09 | -0.08 | -0.01 | -0.07 |
Other Non Operating Income (Expenses) | -0.47 | -0.47 | -0.32 | -3.65 | -0.88 | 0.73 |
EBT Excluding Unusual Items | -14.8 | -17.07 | -16.69 | -25.67 | -22.62 | -23.57 |
Impairment of Goodwill | - | - | -5.87 | - | - | - |
Asset Writedown | -4.66 | -4.66 | -13.33 | -22.77 | -2.09 | - |
Pretax Income | -19.46 | -21.73 | -35.89 | -48.44 | -24.72 | -23.57 |
Income Tax Expense | - | - | -2.09 | -5.85 | -0.06 | -0.12 |
Net Income | -19.46 | -21.73 | -33.81 | -42.59 | -24.66 | -23.46 |
Net Income to Common | -19.46 | -21.73 | -33.81 | -42.59 | -24.66 | -23.46 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 79 | 77 | 72 | 56 | 38 | 51 |
Shares Outstanding (Diluted) | 79 | 77 | 72 | 56 | 38 | 51 |
Shares Change | 7.21% | 6.59% | 28.41% | 45.82% | -24.99% | 5.35% |
EPS (Basic) | -0.24 | -0.28 | -0.47 | -0.76 | -0.64 | -0.46 |
EPS (Diluted) | -0.25 | -0.28 | -0.47 | -0.76 | -0.64 | -0.46 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.11 | -9.24 | -9.92 | -18.23 | -10.13 | -21.85 |
Free Cash Flow Per Share | -0.09 | -0.12 | -0.14 | -0.33 | -0.26 | -0.43 |
Gross Margin | -15.51% | -3.21% | -199.38% | - | -214.09% | 69.08% |
Operating Margin | -3039.84% | -3519.01% | -3282.33% | -5519.37% | -5604.36% | -10999.52% |
Profit Margin | -5202.41% | -5365.68% | -7028.07% | -12134.19% | -8274.16% | -11330.92% |
Free Cash Flow Margin | -1900.27% | -2281.73% | -2062.79% | -5193.45% | -3400.67% | -10553.14% |
EBITDA | -10.09 | -11.94 | -13.29 | -16.67 | -14.09 | -20.64 |
D&A For EBITDA | 1.28 | 2.31 | 2.5 | 2.7 | 2.61 | 2.13 |
EBIT | -11.37 | -14.25 | -15.79 | -19.37 | -16.7 | -22.77 |